<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03067324</url>
  </required_header>
  <id_info>
    <org_study_id>38RC14.041</org_study_id>
    <nct_id>NCT03067324</nct_id>
  </id_info>
  <brief_title>Quality Control of Pancreatic Islet Intended to Islet Graft Cells Intended to Stabilot Islet Graft Protocol</brief_title>
  <acronym>ISLET CHIP</acronym>
  <official_title>Quality Control of Pancreatic Islet Intended to Islet Graft</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Islet quality control after pancreatic islets isolation process is insufficient. The Islet
      Chip study proposes to develop a bio-sensor that will allow a multi-parametric analysis of
      islet graft based on measurement of islet membrane electric potential.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Islet quality control after pancreatic islets isolation process is insufficient. The Islet
      Chip study proposes to develop a bio-sensor that will allow a multi-parametric analysis of
      islet graft based on measurement of islet membrane electric potential.

      The project aims to :

        -  develop the bio-sensor necessary to measure islet membrane electric potential

        -  develop interface between bio-sensor and user

        -  correlate analysis data collected by bio-sensor with metabolic results of islet graft
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 11, 2017</start_date>
  <completion_date type="Anticipated">July 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Months</target_duration>
  <primary_outcome>
    <measure>Beta-score</measure>
    <time_frame>6 months in average before second islet graft</time_frame>
    <description>Beta-score in continuous variable, using the last Beta-score known before the second islet graft. Beta-score is a composite score that reflects pancreatic islet graft function after transplantation and measured from the following criteria: severe hypoglycemia, HbA1c, stimulated C-peptide, fasting glucose, insulin dose or oral diabetes, glycemic variability.</description>
  </primary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pancreatic Islet Quality Control</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      pancreatic islet cells
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients enrolled in STABILOT Pancreatic Islet cell graft protocol and willing to
        participate to ISLET CHIP
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients enrolled in STABILOT Pancreatic Islet cell graft protocol and willing to
             participate to ISLET CHIP

        Exclusion Criteria:

          -  Patients not enrolled in STABILOT Pancreatic Islet cell graft or patients that signed
             the form expressing their refuse to participate to ISLET CHIP.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Sandrine LABLANCHE, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Grenoble</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bogdan CATARGI, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Bordeaux</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sandrine LABLANCHE, MD, PhD</last_name>
    <phone>+33 4 76 63 54 26</phone>
    <email>SLablanche@chu-grenoble.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Myriam HADDOUCHE</last_name>
    <phone>+33476766983</phone>
    <email>MHaddouche@chu-grenoble.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Besançon University Hospital</name>
      <address>
        <city>Besancon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie BOROT, MD, PhD</last_name>
      <phone>+33 3 81 66 82 29</phone>
      <email>sophie.borot@univ-fcomte.fr</email>
    </contact>
    <investigator>
      <last_name>Sophie BOROT, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clermont Ferrand University hospital</name>
      <address>
        <city>Clermont-Ferrand</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Igor TAUVERON, MD, PhD</last_name>
      <phone>+33 4 73 75 15 29</phone>
      <email>itauveron@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>Igor TAUVERON, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Grenoble University Hospital</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandrine LABLANCHE</last_name>
      <phone>+33476769349</phone>
      <email>slablanche@chu-grenoble.fr</email>
    </contact>
    <contact_backup>
      <last_name>Myriam HADDOUCHE</last_name>
      <phone>+33476766983</phone>
      <email>mhaddouche@chu-grenoble.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Sandrine LABLANCHE</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre-Yves BENHAMOU</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lyon University Hospital</name>
      <address>
        <city>Lyon</city>
        <zip>69000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles THIVOLET, MD, PhD</last_name>
      <phone>+33 4 78 86 14 87</phone>
      <email>charles.thivolet@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Charles THIVOLET, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emmanuel MORELON, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lionel BADET, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fanny BURON, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Montpellier University Hospital</name>
      <address>
        <city>Montpellier</city>
        <zip>34000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne WOJTUSCISZYN, MD, PhD</last_name>
      <phone>+33 4 67 33 83 86</phone>
      <email>a-wojtusciszyn@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Anne WOJTUSCISZYN, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eric RENARD, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nancy University hospital</name>
      <address>
        <city>Nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sophie GIRERD, MD, PhD</last_name>
      <phone>+33 3.83.15.31.69</phone>
      <email>s.girerd@chu-nancy.fr</email>
    </contact>
    <investigator>
      <last_name>Luc FRIMAT, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sophie GIRERD, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bruno GUERCI, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University hospital of Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurence KESSLER, MD, PhD</last_name>
      <phone>+33 3 88 11 62 67</phone>
      <email>laurence.kessler@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Laurence KESSLER, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Geneva University Hospital</name>
      <address>
        <city>Geneva</city>
        <zip>CH-1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Kusnik-Joinville O, Weill A, Salanave B, Ricordeau P, Allemand H. Prevalence and treatment of diabetes in France: trends between 2000 and 2005. Diabetes Metab. 2008 Jun;34(3):266-72. doi: 10.1016/j.diabet.2008.01.005. Epub 2008 Jun 3.</citation>
    <PMID>18524662</PMID>
  </reference>
  <reference>
    <citation>Gruessner RW, Gruessner AC. The current state of pancreas transplantation. Nat Rev Endocrinol. 2013 Sep;9(9):555-62. doi: 10.1038/nrendo.2013.138. Epub 2013 Jul 30. Review.</citation>
    <PMID>23897173</PMID>
  </reference>
  <reference>
    <citation>Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW. Automated method for isolation of human pancreatic islets. Diabetes. 1988 Apr;37(4):413-20.</citation>
    <PMID>3288530</PMID>
  </reference>
  <reference>
    <citation>Lablanche S, Borot S, Wojtusciszyn A, Bayle F, Tétaz R, Badet L, Thivolet C, Morelon E, Frimat L, Penfornis A, Kessler L, Brault C, Colin C, Tauveron I, Bosco D, Berney T, Benhamou PY; GRAGIL Network. Five-Year Metabolic, Functional, and Safety Results of Patients With Type 1 Diabetes Transplanted With Allogenic Islets Within the Swiss-French GRAGIL Network. Diabetes Care. 2015 Sep;38(9):1714-22. doi: 10.2337/dc15-0094. Epub 2015 Jun 11.</citation>
    <PMID>26068866</PMID>
  </reference>
  <reference>
    <citation>Lebreton F, Pirog A, Belouah I, Bosco D, Berney T, Meda P, Bornat Y, Catargi B, Renaud S, Raoux M, Lang J. Slow potentials encode intercellular coupling and insulin demand in pancreatic beta cells. Diabetologia. 2015 Jun;58(6):1291-9. doi: 10.1007/s00125-015-3558-z. Epub 2015 Mar 19.</citation>
    <PMID>25788295</PMID>
  </reference>
  <reference>
    <citation>Renaud S, Catargi B, Lang J. Biosensors in diabetes : how to get the most out of evolution and transpose it into a signal. IEEE Pulse. 2014 May-Jun;5(3):30-4. doi: 10.1109/MPUL.2014.2309577. Review.</citation>
    <PMID>24838208</PMID>
  </reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 21, 2017</study_first_submitted>
  <study_first_submitted_qc>February 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 1, 2017</study_first_posted>
  <last_update_submitted>December 4, 2017</last_update_submitted>
  <last_update_submitted_qc>December 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Islet Transplantation</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

